UBS Slashes Oklo Price Target to $60 on Execution Risks; Shares Drop 5%

UBS Triggers Sell-Off with Target Cut

Shares of Oklo Inc. (OKLO) are under significant pressure during Thursday's session, trading down 5.14% to $52.43. The primary catalyst for today's decline is a sharp price target reduction from UBS Group, which lowered its expectations for the stock from $95.00 to $60.00. While the firm maintained a "Neutral" rating, analyst Jon Windham highlighted that the "pre-revenue reality" is beginning to sink in for investors who had previously bid the stock up on nuclear energy hype.

UBS noted that while the long-term outlook for U.S. nuclear development remains cautiously optimistic, Oklo faces substantial near-term hurdles. Specifically, the bank pointed to the risk of significant cost overruns and potential delays in the company’s nuclear build-out plans. The revised $60 target represents a nearly 37% decrease from the previous level, signaling that the path to commercialization for Oklo’s Aurora small modular reactors (SMRs) may be more expensive and time-consuming than initially modeled.

Capital Intensity and Earnings Hangover

Today's move follows a period of volatility for the stock, which has been drifting lower since its March 17 earnings report. In that release, Oklo reported a fourth-quarter 2025 earnings miss, posting a loss of $0.27 per share compared to analyst estimates of a $0.17 loss. The company also provided a sobering look at its 2026 financial needs, guiding for capital expenditures between $350 million and $450 million as it ramps up engineering and construction capacity.

Management’s guidance for 2026 operating outflows of $80 million to $100 million has forced analysts to recalibrate their models. While Oklo boasts a reinforced balance sheet with approximately $2.5 billion in pro forma liquidity—following a massive $1.182 billion capital raise in January—the sheer scale of the investment required to reach criticality at its Idaho and Texas sites is weighing on the stock's valuation multiples.

Insider Selling and Sector Sentiment

Adding to the bearish sentiment are recent SEC filings showing insider activity. CFO Richard Craig Bealmear sold 72,090 shares on March 13 at an average price of $60.00, representing a 15.74% decrease in his position. This follows a larger sale by CEO Jacob DeWitte in January. While such sales are often scheduled, they can create a negative perception when they coincide with a fundamental reassessment of project risks by major brokerages.

In the broader context of the nuclear sector, the "renaissance" remains a dominant theme, fueled by high-profile deals like Oklo’s 1.2-gigawatt agreement with Meta. However, as the industry moves from the "PowerPoint phase" to "steel in the ground," the market is increasingly differentiating between companies with immediate revenue and those, like Oklo, that are years away from operational reactors. Today's pullback in OKLO, which is underperforming the S&P 500 by over 4%, suggests that investors are demanding a higher risk premium for the execution uncertainties inherent in the SMR space.

Forward Outlook

Looking ahead, the market will be laser-focused on Oklo's ability to hit its 2026 milestones, including the targeted criticality for its Groves project. Until the company can demonstrate tangible progress in navigating the Nuclear Regulatory Commission (NRC) licensing process and managing its rising burn rate, the stock is likely to remain sensitive to analyst revisions and sector-wide capital flow shifts.